Published in J Cell Physiol on October 01, 2011
Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia. Circ Res (2015) 1.53
Advances in tenascin-C biology. Cell Mol Life Sci (2011) 1.50
Matrix-dependent perturbation of TGFβ signaling and disease. FEBS Lett (2012) 1.31
Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene (2012) 1.11
Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages. Sci Signal (2016) 1.05
Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Front Physiol (2014) 0.86
Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1. BMC Pulm Med (2014) 0.85
Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability. J Biol Chem (2014) 0.84
Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PLoS One (2013) 0.84
β3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse. PLoS One (2012) 0.84
Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer. Nucleic Acids Res (2015) 0.84
Tenascin-C and integrins in cancer. Cell Adh Migr (2015) 0.82
Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells. J Am Heart Assoc (2014) 0.82
Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Heart Vessels (2013) 0.82
Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1. J Biol Chem (2014) 0.81
Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells. Oncotarget (2013) 0.80
The arterial microenvironment: the where and why of atherosclerosis. Biochem J (2016) 0.77
Divergent modulation of Rho-kinase and Ca(2+) influx pathways by Src family kinases and focal adhesion kinase in airway smooth muscle. Br J Pharmacol (2015) 0.76
Low temperature mitigates cardia bifida in zebrafish embryos. PLoS One (2013) 0.75
Smooth Muscle Stiffness Sensitivity is Driven by Soluble and Insoluble ECM Chemistry. Cell Mol Bioeng (2015) 0.75
Integrin signaling in atherosclerosis. Cell Mol Life Sci (2017) 0.75
Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia. J Transl Med (2016) 0.75
Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest (2004) 2.76
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol (2003) 1.74
Visualizing the dynamics of cerebral aneurysms with four-dimensional computed tomographic angiography. Neurosurgery (2005) 1.49
Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis. Cardiovasc Res (2007) 1.48
Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol (2005) 1.46
¹¹C-PiB PET imaging of encephalopathy associated with cerebral amyloid angiopathy. Intern Med (2014) 1.41
Method of cell transplantation promoting the organization of intraarterial thrombus. Circulation (2005) 1.40
Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther (2013) 1.38
Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. J Clin Invest (2004) 1.34
Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion. Int J Exp Pathol (2004) 1.33
Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. J Neurosci (2002) 1.31
Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer (2003) 1.21
A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest (2007) 1.19
A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy. Nat Med (2005) 1.19
Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res (2008) 1.18
Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol (2002) 1.16
Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol (2011) 1.16
Low wall shear stress is independently associated with the rupture status of middle cerebral artery aneurysms. Stroke (2012) 1.13
The targeted disruption of the MYPT1 gene results in embryonic lethality. Transgenic Res (2005) 1.12
Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol (2003) 1.12
Periprocedural hemodynamic instability with carotid angioplasty and stenting. Surg Neurol (2008) 1.12
Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart. Cell Signal (2006) 1.11
Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol (2006) 1.10
Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2010) 1.08
Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol (2006) 1.07
Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci (2003) 1.07
Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development (2002) 1.05
Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J Neurosci Res (2002) 1.05
Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol (2007) 1.05
Endovascular management of vertebral artery dissecting aneurysms: review of 25 patients. Turk Neurosurg (2010) 1.04
T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc Natl Acad Sci U S A (2009) 1.04
Thrombin-cleaved osteopontin levels in synovial fluid correlate with disease severity of knee osteoarthritis. J Rheumatol (2010) 1.04
Matricellular proteins: new molecular targets to prevent heart failure. Cardiovasc Ther (2011) 1.04
The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation (2003) 1.03
A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem (2007) 1.02
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology (2005) 1.00
Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy. J Neuropathol Exp Neurol (2006) 0.99
Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. Protein Sci (2005) 0.98
Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2003) 0.97
Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurol (2006) 0.96
Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res (2007) 0.96
Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy. Circ J (2007) 0.96
Densin-180, a synaptic protein, links to PSD-95 through its direct interaction with MAGUIN-1. Genes Cells (2002) 0.95
Development of a model of seizure-induced hippocampal injury with features of programmed cell death in the BALB/c mouse. J Neurosci Res (2004) 0.94
MMP-2 expression is associated with rapidly proliferative arteriosclerosis in the flexor tenosynovium and pain severity in carpal tunnel syndrome. J Pathol (2005) 0.93
High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol (2009) 0.92
Beta-tricalcium phosphate as a substitute for autograft in interbody fusion cages in the canine lumbar spine. J Neurosurg (2002) 0.92
Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur J Immunol (2006) 0.92
High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Radiat Med (2005) 0.91
Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp Neurol (2006) 0.91
Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol Dis (2012) 0.91
Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer. Clin Cancer Res (2002) 0.90
α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation. J Immunol (2011) 0.90
Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C. Circulation (2002) 0.90
MRI findings of malignant transformation of epidermoid cyst: case report. J Neurooncol (2006) 0.90
Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis. J Pathol (2005) 0.89
Human eye fields in the frontal lobe as studied by epicortical recording of movement-related cortical potentials. Brain (2004) 0.89
Diffusion-weighted magnetic resonance imaging in carotid angioplasty and stenting with balloon embolic protection devices. Neuroradiology (2006) 0.89
Regulation of tenascin-C expression by tumor necrosis factor-alpha in cultured human osteoarthritis chondrocytes. J Rheumatol (2007) 0.88
Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis. J Rheumatol (2009) 0.88
Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice. Cardiovasc Res (2005) 0.88
Access site complications with carotid angioplasty and stenting. Surg Neurol (2007) 0.88
High-risk plaque for carotid artery stenting evaluated with 3-dimensional T1-weighted gradient echo sequence. Stroke (2012) 0.88
Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: assessment by 125I-anti-tenascin-C antibody imaging. J Nucl Med (2010) 0.88
Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. J Rheumatol (2004) 0.88
Apparent diffusion coefficient of subcutaneous epidermal cysts in the head and neck comparison with intracranial epidermoid cysts. Acad Radiol (2007) 0.87
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. J Neurosurg (2010) 0.87